HopeStage
Back to all studies
CompletedNCT00044044

Lurasidone compared with placebo and haloperidol for schizophrenia

About this titleRead the official source — NCT00044044

Researchers compared Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and placebo, tracking side effects to assess safety in people with schizophrenia.

Medication studyAges 18–64United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and placebo, tracking side effects to assess safety in people with schizophrenia.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.

Listed locations
Birmingham and 33 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 2002
Recruitment status
Completed
Enrollment listed in the registry
356
Sponsor
Sumitomo Pharma America, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT00044044
Official title
Show the full official title

A 6-Week, Double-Blind, Randomized, Fixed-Dose, Parallel-Group Study of the Efficacy and Safety of Three Dose Levels of SM-13496 Compared to Placebo and Haloperidol in Patients With Schizophrenia Who Are Experiencing an Acute Exacerbation of Symptoms

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · Cerritos · Garden Grove

26 more locations
  • Glendale
  • La Mesa
  • Orange
  • San Diego
  • Washington D.C.
  • Melbourne
  • North Miami
  • Tampa
  • Winter Park
  • Atlanta
  • Smyrna
  • Honolulu
  • Hoffman Estates
  • Oak Brook
  • Rockville
  • North Las Vegas
  • Clementon
  • Kenilworth
  • Cincinnati
  • Philadelphia
  • Austin
  • Bellaire
  • Dallas
  • Falls Church
  • Belleview
  • Milwaukee

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and placebo, tracking side effects to assess safety in people with schizophrenia.

Who is behind this study?

The study sponsor is Sumitomo Pharma America, Inc., a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and Placebo.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies